edited by Helmut Kewitz, Ivar Roots, Karlheinz Voigt.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Berlin, Heidelberg
Name of Publisher, Distributor, etc.
Springer Berlin Heidelberg
Date of Publication, Distribution, etc.
1987
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(XII, 148 pages 32 illustrations)
CONTENTS NOTE
Text of Note
Opening Remarks --;The Thalidomide Hypothesis: How It Was Found and Tested --;Reasons for the Successes and Failures of Specific Models in Drug Epidemiology --;Methodological Concepts: What Could We Know and What Should We Know in Drug Epidemiology --;The Design of Case-Control Studies --;Methodological Evaluation of Studies in Drug Epidemiology --;Problems with International Evaluation of Drug Risks --;Drug Utilization Studies --;an Instrument in Drug Research --;Observational Cohort Study in General Practice: Differences and Equivalences Among Analgesics for Treatment of Colic Pain --;Oxprenolol in Myocardial Infarction Survivors: Brief Review of the European Infarction Study Results in the Light of Other Beta-Blocker Post Infarction Trials --;The Epidemiological Evaluation of Major Upper Gastrointestinal Bleeding in Relation to Aspirin Use --;The Role of Pharmacogenetics in Drug Epidemiology --;Possibilities and Limitations of a Modified Spontaneous ADR Monitoring System Available to Practitioners in Germany --;Prescription of Psychotropic Drugs in Germany --;The Benefit-Risk Evaluation of Drugs by Health Authorities in the Federal Republic of Germany --;Postmarketing Surveillance of Drugs: Visions of the Future --;Closing Remarks.
SUMMARY OR ABSTRACT
Text of Note
Clinical pharmacology is not primarily characterized by a particular methodology, but rather by the aims it pursues. Cooperation with scientists in other fields is thus essential. The symposium "Epidemiological Concepts in Clinical Pharmacology" (November 28-29, 1985) was organized by the Institute of Clinical Pharmacology of the Free University of Berlin to acknowledge the increasing impact of epidemioƯ logical methods and thinking on clinical pharmacology. The editors are glad that all the presentations of the leading experts can now be made available to a broader reaƯ dership. Neither the symposium itself nor publication of the proceedings would have been possible without the generous support received from the Paul-Martini-StifƯ tung and from the Free University of Berlin. To these institutions we owe deep gratiƯ tude. The expert guidance we received from Dr. Ute Heilmann of Springer-Verlag is also gladly acknowledged. Berlin, November 1986 H. Kewitz I. Roots K. Voigt Contents Opening Remarks 1 H. Kewitz ... The Thalidomide Hypothesis: How It Was Found and Tested W. Lenz ... 3 Reasons for the Successes and Failures of Specific Models in Drug Epidemiology S. Shapiro ... ... ... ... ... .. . . 11 ... Methodological Concepts: What Could We Know and What Should We Know in Drug Epidemiology K. Obeda. ... ... ... ... ... . 23 ... The Design of Case-Control Studies H.J. Jesdinsky ... . ... 34 Methodological Evaluation of Studies in Drug Epidemiology O.P. Heinonen. ... ... ... ... .. . . 43 ... . Problems with International Evaluation of Drug Risks A. Liljestrand ... ... . . 50 Drug Utilization Studies -an Instrument in Drug Research P.K.M. Lunde, M. Andrew, I. Baksaas ... ... . . .. . . 57.
TOPICAL NAME USED AS SUBJECT
Medicine.
Pharmacy.
Toxicology.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RM301
Book number
.
E358
1987
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Helmut Kewitz, Ivar Roots, Karlheinz Voigt.